0001832539-20-000001.txt : 20201117
0001832539-20-000001.hdr.sgml : 20201117
20201117113411
ACCESSION NUMBER: 0001832539-20-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20201117
DATE AS OF CHANGE: 20201117
EFFECTIVENESS DATE: 20201117
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Orphion Therapeutics, Inc.
CENTRAL INDEX KEY: 0001832539
IRS NUMBER: 831675815
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-380761
FILM NUMBER: 201319918
BUSINESS ADDRESS:
STREET 1: 57 MEADOW WOODS ROAD
CITY: GREAT NECK
STATE: NY
ZIP: 11020
BUSINESS PHONE: 9179515659
MAIL ADDRESS:
STREET 1: 57 MEADOW WOODS ROAD
CITY: GREAT NECK
STATE: NY
ZIP: 11020
D
1
primary_doc.xml
X0708
D
LIVE
0001832539
Orphion Therapeutics, Inc.
57 MEADOW WOODS ROAD
GREAT NECK
NY
NEW YORK
11020
9179515659
DELAWARE
None
None
Corporation
true
2020
Jason
Slakter
c/o Orphion Therapeutics, Inc.
57 Meadow Woods Road
Great Neck
NY
NEW YORK
11020
Executive Officer
Director
Michael
Mashaal
c/o Orphion Therapeutics, Inc.
57 Meadow Woods Road
Great Neck
NY
NEW YORK
11020
Director
Nickolay
Voronin
c/o Orphion Therapeutics, Inc.
57 Meadow Woods Road
Great Neck
NY
NEW YORK
11020
Director
Pharmaceuticals
Decline to Disclose
- 06b
false
2020-11-10
true
true
false
0
16332500
5332500
11000000
false
4
0
250000
true
0
false
Orphion Therapeutics, Inc.
Jason Slakter
Jason Slakter
Chief Executive Officer
2020-11-17